Matches in SemOpenAlex for { <https://semopenalex.org/work/W2615851217> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2615851217 endingPage "1318691" @default.
- W2615851217 startingPage "1318691" @default.
- W2615851217 abstract "Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED budget impact and cost-effectiveness analyses for LGS suggest that adding clobazam to a health plan formulary may result in decreased medical costs; however, research on clinical and economic outcomes and treatment patterns with these AED treatments in LGS is limited.Objectives: To compare the baseline characteristics and treatment patterns of new initiators of clobazam and other AEDs among LGS patients and compare healthcare utilization and costs before and after clobazam initiation among LGS patients.Methods: A retrospective study of probable LGS patients was conducted using the MarketScan® Commercial, Medicare Supplemental, and Medicaid databases (10/1/2010-3/31/2014).Results: In the Commercial/Medicare Supplemental population, clobazam users were younger, had fewer comorbidities, and more prior AED use than non-clobazam users. In the 12 months pre-treatment initiation, clobazam users had significantly more seizure-related inpatient stays and outpatient visits and higher total seizure-related (P < 0.001) and all-cause (P < 0.001) costs than non-clobazam users. Among clobazam users, when compared to the 12 months pre-clobazam initiation, seizure-related medical utilization and costs were lower in the 12 months post-clobazam initiation (P = 0.004). Total all-cause (P < 0.001) and seizure-related (P = 0.029) costs increased post-clobazam initiation mainly due to the increase in outpatient pharmacy costs. Similar results were observed in the Medicaid population.Conclusions: Baseline results suggest a prescribing preference for clobazam in severe LGS patients. Clobazam users had a reduction in seizure-related medical utilization and costs after clobazam initiation. The improvement in medical costs mostly offset the higher prescription costs following clobazam initiation." @default.
- W2615851217 created "2017-05-26" @default.
- W2615851217 creator A5009030222 @default.
- W2615851217 creator A5026174766 @default.
- W2615851217 creator A5026201262 @default.
- W2615851217 creator A5039974101 @default.
- W2615851217 creator A5041203224 @default.
- W2615851217 creator A5050047621 @default.
- W2615851217 creator A5074920417 @default.
- W2615851217 creator A5084268690 @default.
- W2615851217 date "2017-01-01" @default.
- W2615851217 modified "2023-10-01" @default.
- W2615851217 title "Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome" @default.
- W2615851217 cites W1671458509 @default.
- W2615851217 cites W1981535076 @default.
- W2615851217 cites W2014460514 @default.
- W2615851217 cites W2031056359 @default.
- W2615851217 cites W2046954212 @default.
- W2615851217 cites W2079682587 @default.
- W2615851217 cites W2081380386 @default.
- W2615851217 cites W2083500529 @default.
- W2615851217 cites W2090654277 @default.
- W2615851217 cites W2103530438 @default.
- W2615851217 cites W2104825304 @default.
- W2615851217 cites W2133016973 @default.
- W2615851217 cites W2137728866 @default.
- W2615851217 cites W2151729238 @default.
- W2615851217 cites W2290301262 @default.
- W2615851217 cites W2334885616 @default.
- W2615851217 doi "https://doi.org/10.1080/20016689.2017.1318691" @default.
- W2615851217 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5508372" @default.
- W2615851217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28740620" @default.
- W2615851217 hasPublicationYear "2017" @default.
- W2615851217 type Work @default.
- W2615851217 sameAs 2615851217 @default.
- W2615851217 citedByCount "5" @default.
- W2615851217 countsByYear W26158512172017 @default.
- W2615851217 countsByYear W26158512172019 @default.
- W2615851217 countsByYear W26158512172021 @default.
- W2615851217 countsByYear W26158512172022 @default.
- W2615851217 countsByYear W26158512172023 @default.
- W2615851217 crossrefType "journal-article" @default.
- W2615851217 hasAuthorship W2615851217A5009030222 @default.
- W2615851217 hasAuthorship W2615851217A5026174766 @default.
- W2615851217 hasAuthorship W2615851217A5026201262 @default.
- W2615851217 hasAuthorship W2615851217A5039974101 @default.
- W2615851217 hasAuthorship W2615851217A5041203224 @default.
- W2615851217 hasAuthorship W2615851217A5050047621 @default.
- W2615851217 hasAuthorship W2615851217A5074920417 @default.
- W2615851217 hasAuthorship W2615851217A5084268690 @default.
- W2615851217 hasBestOaLocation W26158512171 @default.
- W2615851217 hasConcept C100406419 @default.
- W2615851217 hasConcept C118552586 @default.
- W2615851217 hasConcept C187212893 @default.
- W2615851217 hasConcept C2777907850 @default.
- W2615851217 hasConcept C2778186239 @default.
- W2615851217 hasConcept C2779307984 @default.
- W2615851217 hasConcept C512399662 @default.
- W2615851217 hasConcept C71924100 @default.
- W2615851217 hasConceptScore W2615851217C100406419 @default.
- W2615851217 hasConceptScore W2615851217C118552586 @default.
- W2615851217 hasConceptScore W2615851217C187212893 @default.
- W2615851217 hasConceptScore W2615851217C2777907850 @default.
- W2615851217 hasConceptScore W2615851217C2778186239 @default.
- W2615851217 hasConceptScore W2615851217C2779307984 @default.
- W2615851217 hasConceptScore W2615851217C512399662 @default.
- W2615851217 hasConceptScore W2615851217C71924100 @default.
- W2615851217 hasIssue "1" @default.
- W2615851217 hasLocation W26158512171 @default.
- W2615851217 hasLocation W26158512172 @default.
- W2615851217 hasLocation W26158512173 @default.
- W2615851217 hasLocation W26158512174 @default.
- W2615851217 hasLocation W26158512175 @default.
- W2615851217 hasOpenAccess W2615851217 @default.
- W2615851217 hasPrimaryLocation W26158512171 @default.
- W2615851217 hasRelatedWork W1993260480 @default.
- W2615851217 hasRelatedWork W2018623154 @default.
- W2615851217 hasRelatedWork W2040021578 @default.
- W2615851217 hasRelatedWork W2089104512 @default.
- W2615851217 hasRelatedWork W2092231439 @default.
- W2615851217 hasRelatedWork W2152598089 @default.
- W2615851217 hasRelatedWork W2396520718 @default.
- W2615851217 hasRelatedWork W2790739193 @default.
- W2615851217 hasRelatedWork W4313311983 @default.
- W2615851217 hasRelatedWork W4318027231 @default.
- W2615851217 hasVolume "5" @default.
- W2615851217 isParatext "false" @default.
- W2615851217 isRetracted "false" @default.
- W2615851217 magId "2615851217" @default.
- W2615851217 workType "article" @default.